Machado Norman Oneil, Al Qadhi Hani, Al Wahaibi Khalifa, Rizvi Syed G
Department of Surgery, Sultan Qaboos University Hospital, Muscat, Oman.
Department of Family Medicine and Public Health, Muscat, Oman.
JSLS. 2015 Jul-Sep;19(3). doi: 10.4293/JSLS.2015.00036.
Adrenocortical cancer (ACC) is a rare disease that is difficult to treat. Laparoscopic adrenalectomy (LA) is performed, even for large adrenocortical carcinomas. However, the oncological effectiveness of LA remains unclear. This review presents the current knowledge of the feasibility and oncological effectiveness of laparoscopic surgery for ACC, with an analysis of data for outcomes and other parameters.
A systematic review of the literature was performed by searching the PubMed and Medline databases for all relevant articles in English, published between January 1992 and August 2014 on LA for adrenocortical carcinoma.
The search resulted in retrieval of 29 studies, of which 10 addressed the outcome of LA versus open adrenalectomy (OA) and included 844 patients eligible for this review. Among these, 206 patients had undergone LA approaches, and 638 patients had undergone OA. Among the 10 studies that compared the outcomes obtained with LA and OA for ACC, 5 noted no statistically significant difference between the 2 groups in the oncological outcomes of recurrence and disease-free survival, whereas the remaining 5 reported inferior outcomes in the LA group. Using a paired t test for statistical analysis, except for tumor size, we found no significant difference in local recurrence, peritoneal carcinomatosis, positive resection margin, and time to recurrence between the LA and OA groups. The overall mean tumor size in patients undergoing LA and OA was 7.1 and 11.2 cm, respectively (P = .0003), and the mean overall recurrence was 61.5 and 57.9%, respectively. The outcome of LA is believed to depend to a large extent on the size and stage of the lesion (I and II being favorable) and the surgical expertise in the center where the patient undergoes the operation. However, the present review shows no difference in the outcome between the 2 approaches across all stages. A poor outcome is likely to result from inadequate surgery, irrespective of whether the approach is open or laparoscopic.
肾上腺皮质癌(ACC)是一种罕见且难以治疗的疾病。即便对于较大的肾上腺皮质癌,也会施行腹腔镜肾上腺切除术(LA)。然而,LA的肿瘤学疗效仍不明确。本综述介绍了腹腔镜手术治疗ACC的可行性和肿瘤学疗效的当前知识,并对结果及其他参数数据进行了分析。
通过检索PubMed和Medline数据库,对1992年1月至2014年8月期间发表的所有关于LA治疗肾上腺皮质癌的英文相关文章进行了系统的文献综述。
检索结果共获取29项研究,其中10项涉及LA与开放性肾上腺切除术(OA)的结果对比,纳入了844例符合本综述条件的患者。其中,206例患者接受了LA手术,638例患者接受了OA手术。在这10项比较LA和OA治疗ACC结果的研究中,5项指出两组在复发和无病生存的肿瘤学结果上无统计学显著差异,而其余5项报告LA组的结果较差。采用配对t检验进行统计分析,除肿瘤大小外,我们发现LA组和OA组在局部复发、腹膜种植、手术切缘阳性及复发时间方面无显著差异。接受LA和OA手术患者的总体平均肿瘤大小分别为7.1 cm和11.2 cm(P = .0003),总体平均复发率分别为61.5%和57.9%。LA的结果在很大程度上被认为取决于病变的大小和分期(I期和II期预后较好)以及患者接受手术的中心的手术专业水平。然而,本综述显示在所有分期中两种手术方式的结果无差异。无论手术方式是开放还是腹腔镜,手术不充分都可能导致不良后果。